These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 36599262)

  • 1. The impact of killer cell immunoglobulin-like receptor (KIR) genes and human leukocyte antigen (HLA) class I ligands on predisposition or protection against prostate cancer.
    Roshan Zamir M; Ariafar A; Ghaderi A; Amirzargar A
    Immunobiology; 2023 Mar; 228(2):152319. PubMed ID: 36599262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of killer cell immunoglobulin-like receptors and their cognate HLA class I ligands with susceptibility to acute myeloid leukemia in Iranian patients.
    Mirzazadeh S; Bemani P; Halimi H; Sanaee MN; Karami N; Ramzi M; Farjadian S
    Sci Rep; 2023 Jul; 13(1):11456. PubMed ID: 37454198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound KIR-HLA genotype analyses in the Iranian population by a novel PCR-SSP assay.
    Tajik N; Shahsavar F; Nasiri M; Radjabzadeh MF
    Int J Immunogenet; 2010 Jun; 37(3):159-68. PubMed ID: 20193031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KIR3DL1+HLA-B Bw4Ile80 and KIR2DS1+HLA-C2 combinations are both associated with ankylosing spondylitis in the Iranian population.
    Tajik N; Shahsavar F; Poormoghim H; Radjabzadeh MF; Mousavi T; Jalali A
    Int J Immunogenet; 2011 Oct; 38(5):403-9. PubMed ID: 21797986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of killer cell immunoglobulin-like receptors (KIRs) and their HLA ligand genes polymorphisms in Iranian patients with systemic sclerosis.
    Mahmoudi M; Fallahian F; Sobhani S; Ghoroghi S; Jamshidi A; Poursani S; Dolati M; Hosseinpour Z; Gharibdoost F
    Clin Rheumatol; 2017 Apr; 36(4):853-862. PubMed ID: 28120169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of inhibitory and activating killer-cell immunoglobulin-like receptors to the same cognate HLA-C2 and Bw4 ligands confer breast cancer risk.
    Ashouri E; Rajalingam K; Barani S; Farjadian S; Ghaderi A; Rajalingam R
    Sci Rep; 2021 Apr; 11(1):7932. PubMed ID: 33846431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes to Predict the Occurrence of Acute Allograft Rejection after Kidney Transplantation.
    Jafari D; Nafar M; Yekaninejad MS; Abdolvahabi R; Lesan Pezeshki M; Razaghi E; Amirzargar AA
    Iran J Allergy Asthma Immunol; 2017 Jun; 16(3):245-255. PubMed ID: 28732438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of Killer Cell Immunoglobulin-Like Receptor Genes and Their HLA Ligands in Inflammatory Bowel Diseases.
    Beigmohammadi F; Mahmoudi M; Karami J; Ahmadzadeh N; Ebrahimi-Daryani N; Rezaei N
    J Immunol Res; 2020; 2020():4873648. PubMed ID: 33015197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic profiles of killer-cell immunoglobulin-like receptors and HLA ligands in Thai blood donors.
    Kitpoka P; Tammakorn C; Chaisri S; Leelayuwat C; Mongkolsuk T; Thammanichanond D
    Hum Immunol; 2016 Jun; 77(6):470-5. PubMed ID: 27131859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hybrid qPCR/SNP array approach allows cost efficient assessment of KIR gene copy numbers in large samples.
    Pontikos N; Smyth DJ; Schuilenburg H; Howson JM; Walker NM; Burren OS; Guo H; Onengut-Gumuscu S; Chen WM; Concannon P; Rich SS; Jayaraman J; Jiang W; Traherne JA; Trowsdale J; Todd JA; Wallace C
    BMC Genomics; 2014 Apr; 15():274. PubMed ID: 24720548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic associations of killer immunoglobulin like receptors and class I human leukocyte antigens on childhood acute lymphoblastic leukemia among north Indians.
    Misra MK; Prakash S; Moulik NR; Kumar A; Agrawal S
    Hum Immunol; 2016 Jan; 77(1):41-46. PubMed ID: 26472014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphism of NK receptors and their ligands in melanoma patients: prevalence of inhibitory over activating signals.
    Naumova E; Mihaylova A; Stoitchkov K; Ivanova M; Quin L; Toneva M
    Cancer Immunol Immunother; 2005 Feb; 54(2):172-8. PubMed ID: 15248031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. KIR/HLA gene combinations influence susceptibility to B-cell chronic lymphocytic leukemia and the clinical course of disease.
    Karabon L; Jedynak A; Giebel S; Wołowiec D; Kielbinski M; Woszczyk D; Kapelko-Slowik K; Kuliczkowski K; Frydecka I
    Tissue Antigens; 2011 Aug; 78(2):129-38. PubMed ID: 21726204
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory natural killer cell receptor KIR3DL1 with its ligand Bw4 constraints HIV-1 disease among South Indians.
    Maruthamuthu S; Rajalingam R; Pandian K; Madasamy S; Manoharan M; Pitchai L; Murugesan A; Mariakuttikan J
    AIDS; 2018 Nov; 32(18):2679-2688. PubMed ID: 30289808
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Killer Cell Immunoglobulin-Like Receptors and Their HLA-Ligands with Type 1 Diabetes Among South Indian Population.
    Gunavathy N; Asirvatham A; Chitra A; Jayalakshmi M
    Immunol Invest; 2023 Apr; 52(3):270-285. PubMed ID: 36705596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Susceptibility to pulmonary tuberculosis in Iranian individuals is not affected by compound KIR/HLA genotype.
    Tajik N; Shah-hosseini A; Mohammadi A; Jafari M; Nasiri M; Radjabzadeh MF; Farnia P; Jalali A
    Tissue Antigens; 2012 Feb; 79(2):90-6. PubMed ID: 22128749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activating KIR/HLA-I combinations as a risk factor of adult B-ALL.
    Halimi H; Mirzazadeh S; Kalantar K; Hajimaghsoodi M; Ramzi M; Farjadian S
    Hum Immunol; 2024 Mar; 85(2):110750. PubMed ID: 38262874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of killer cell immunoglobulin-like receptors and their human leukocyte antigen-ligands gene polymorphisms in Iranian patients with systemic lupus erythematosus.
    Akhtari M; Farazmand A; Mahmoudi M; Akbarian M; Ahmadzadeh N; Mirkazemi Z; Mostafaei S; Jamshidi AR
    Lupus; 2016 Oct; 25(11):1244-53. PubMed ID: 26989167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. KIR2DS1, 2DS5, 3DS1 and KIR2DL5 are associated with the risk of head and neck squamous cell carcinoma in Iranians.
    Barani S; Khademi B; Ashouri E; Ghaderi A
    Hum Immunol; 2018 Apr; 79(4):218-223. PubMed ID: 29408295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of KIR genes and their HLA ligands in susceptibility to dengue in a population from southern Brazil.
    Beltrame LM; Sell AM; Moliterno RA; Clementino SL; Cardozo DM; Dalalio MM; Fonzar UJ; Visentainer JE
    Tissue Antigens; 2013 Dec; 82(6):397-404. PubMed ID: 24498996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.